Chugai Pharmaceutical Co., Ltd.
CHGCF
$47.72
$1.312.82%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -- | -40.96% | -10.43% | -39.36% | -16.97% |
| Total Depreciation and Amortization | -- | -7.14% | -5.85% | -5.85% | -3.55% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -68.42% | -42.00% | 14.56% | 15.60% |
| Change in Net Operating Assets | -- | 323.78% | 58.14% | 34.51% | 103.36% |
| Cash from Operations | -- | 41.26% | 2.29% | 0.59% | 15.95% |
| Capital Expenditure | -- | -12.64% | 1.01% | 36.17% | 4.23% |
| Sale of Property, Plant, and Equipment | -- | -58.53% | -103.45% | -103.58% | 457.07% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -9.09% | -3,431.59% | -1,227.61% | 106.15% |
| Cash from Investing | -- | -17.68% | -681.95% | -420.46% | 78.57% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 28.21% | 21.64% | -22.58% | -20.47% |
| Repurchase of Common Stock | -- | 12.50% | -14.29% | -100.00% | -40.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -19.57% | -19.64% | 5.86% | 5.76% |
| Other Financing Activities | -- | -49.43% | -26.56% | -50.07% | -0.78% |
| Cash from Financing | -- | -18.40% | -18.29% | 5.93% | 5.72% |
| Foreign Exchange rate Adjustments | -- | -123.85% | -127.62% | -40.52% | 245.10% |
| Miscellaneous Cash Flow Adjustments | -- | 153.49% | -181.94% | 111.27% | 194.74% |
| Net Change in Cash | -- | 229.10% | -116.37% | -67.40% | 646.68% |